Neftaly Inpatient statin use and secondary stroke prevention

Introduction

Stroke survivors face a substantial risk of recurrent cerebrovascular events, making secondary prevention a critical aspect of stroke care. Among various interventions, statin therapy has emerged as a cornerstone in reducing recurrent ischemic stroke and improving long-term outcomes.

At Neftaly, we emphasize the importance of timely initiation and adherence to statin treatment during the inpatient stay as part of comprehensive secondary prevention strategies.

---

The Role of Statins in Secondary Stroke Prevention

Statins (HMG-CoA reductase inhibitors) lower low-density lipoprotein cholesterol (LDL-C) and have pleiotropic effects, including anti-inflammatory and plaque-stabilizing properties. Their benefits in stroke survivors include:

• Reducing the risk of recurrent ischemic stroke
• Lowering the incidence of major cardiovascular events such as myocardial infarction
• Improving endothelial function and cerebral blood flow
• Decreasing systemic inflammation contributing to atherosclerosis progression

---

Evidence Supporting Inpatient Statin Initiation

• Landmark trials such as SPARCL demonstrated that high-intensity statins significantly reduce stroke recurrence risk.
• Early initiation of statins during the hospital stay is associated with better compliance and improved outcomes compared to delayed or outpatient-only initiation.
• Guidelines recommend starting or continuing statins in all eligible patients with ischemic stroke or TIA unless contraindicated.

---

Challenges in Inpatient Statin Use

• Under-prescription due to lack of awareness, clinical inertia, or concerns about adverse effects.
• Variability in adherence to guidelines across hospitals and stroke units.
• Insufficient monitoring and follow-up post-discharge, leading to treatment discontinuation.
• Managing statin therapy in patients with hemorrhagic stroke or complex comorbidities requires careful clinical judgment.

---

Strategies to Enhance Statin Use for Secondary Prevention

1. Standardized Protocols

• Implement stroke unit protocols mandating statin evaluation and initiation for all eligible patients.
• Integrate statin prescription into electronic discharge checklists.

2. Multidisciplinary Approach

• Engage neurologists, pharmacists, nurses, and rehabilitation teams in medication reconciliation and patient counselling.
• Early involvement of clinical pharmacists to optimize statin dosing and manage side effects.

3. Patient Education

• Inform patients and caregivers about the benefits and safety of statins.
• Address misconceptions and encourage adherence through clear communication.

4. Post-Discharge Follow-Up

• Ensure outpatient follow-up for lipid monitoring and therapy adjustment.
• Use telehealth and reminder systems to support medication adherence.

---

Neftaly’s Support for Improving Statin Use in Stroke Care

???? Clinical Training

• Workshops and online modules on evidence-based secondary prevention, including statin therapy.
• Training on managing statin intolerance and interactions.

???? Quality Improvement Initiatives

• Auditing statin prescription rates and identifying barriers.
• Providing feedback and best practices to healthcare teams.

???? Decision Support Tools

• Implementing clinical decision support systems to prompt statin initiation.
• Integration with electronic health records to flag eligible patients.

---

Conclusion

Statins are a proven, cost-effective intervention for reducing recurrent stroke risk and improving vascular health. Early and consistent inpatient use of statins, combined with ongoing patient support, is vital to successful secondary stroke prevention.

Neftaly is committed to empowering stroke care teams to optimize statin use, improving survival and quality of life for stroke survivors worldwide.